NCT05944692View on ClinicalTrials.gov

Epilepsy Seizure Detection With Innovative Tripolar EEG (tEEG)

Not yet recruitingOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

August 3, 2026

Study Completion Date

August 3, 2026

Conditions
Epilepsy
Interventions
DEVICE

Tripolar electroencephalography

We will record physiological signals with the tripolar electroencephalography

Trial Locations (2)

85013

Barrow Neurological Institute Dignity Health dba St. Joseph's Hospital and Medical Center, Phoenix

02115

Boston Children's Hospital, Boston

Sponsors

Lead Sponsor

CREmedical
All Listed Sponsors
collaborator

Boston Children's Hospital

OTHER

collaborator

Barrow Neurological Institute

OTHER

lead

CREmedical

INDUSTRY

NCT05944692 - Epilepsy Seizure Detection With Innovative Tripolar EEG (tEEG) | Biotech Hunter | Biotech Hunter